Anti Tuberculosis Flashcards
What are the first line agents for anti-tuberculosis drugs
First-line agents
• Rifampin
• Isoniazid (INH)
• Pyrazinamide
• Ethambutol
ISONIAZD
Mechanism of action:
Resistance:
Pharmacokinetics:
Mechanism of action:
• prodrug and must be activated by bacterial catalase peroxidase
(KatG).
• inhibits synthesis of mycolic acids
Resistance:
• under expression of enzyme (KatG) required for activation
Pharmacokinetics:
• Metabolism - acetylation by liver N-acetyltransferase
-genetically determined
-rapid acetylators – decreased plasma conc
-slow acetylators - increased plasma conc
ISONIAZID Adverse Reactions
Hepatitis
• Drug-induced systemic lupus erythematosus
• Peripheral neuropathy
- relative pyridoxine deficiency
- more likely to occur in slow acetylators
• Sideroblastic anemia
Rifampin
MOA
Resistance
Pharmacokinetics
Adverse Rxn
MOA: *Binds to the β subunit of bacterial DNA-dependent RNA polymerase *Inhibits RNA synthesis
Resistance:point mutations in the gene
for the β subunit of RNA polymerase. *reduced binding of rifampin
to RNA polymerase.
Pharmacokinetics:
• Strong inducer most cytochrome P450 isoforms (CYP1A2,2C9, 2C19, 2D6, and 3A4)
Adverse Reactions:
• imparts a harmless orange color to urine, sweat, and tears
• cholestatic jaundice and occasionally hepatitis
• light-chain proteinuria
• a flu-like syndrome characterized by fever, chills, myalgias,
anemia, and thrombocytopenia.
• acute tubular necrosis
Ethambutol
MOA
Resistance
Adverse Rxn
MOA: Inhibits mycobacterial
arabinosyl transferases
• Inhibits polymerization
reaction of arabinoglycan,
an essential component of
the mycobacterial cell wall
Resistance:
Resistance• mutations resulting in
overexpression of gene for
arabinosyl transferases
Adverse Rxn:retrobulbar neuritis
- The most common serious adverse event
- loss of visual acuity and red-green color blindness
PYRAZINAMIDE (PZA)
MOA
Resistance
Adverse Rxn
Mechanism of Action:
• Pyrazinamide is converted to pyrazinoic acid—the active
form of the drug—by mycobacterial pyrazinamidase
• Pyrazinoic acid disrupts mycobacterial cell membrane
metabolism and transport functions.
Resistance:
• impaired uptake of pyrazinamide
• mutations in pyrazinamidase that impair conversion of PZA to its active form
Adverse Reactions:
• hepatotoxicity
• hyperuricemia
What’s the treatment protocols for active infection in the intensive phase?
Two months of Rifampin: PLUS Isoniazid , Pyrazinamide ,
and Ethambutol
What’s the treatment protocols for active infection in the continuation phase?
Four months of Rifampin: PLUS Isoniazid
❑Adjuvant treatment
• Pyridoxine
What’s the treatment protocols for active infection in the latent infection phase?
isoniazid for 9 months
Second-line drugs for tuberculosis
• Streptomycin
• Amikacin
• Capreomycin
• Aminosalicylic acid
• Clofazimine
• Cycloserine
• Ethionamide
• Levofloxacin
• Moxifloxacin
• Linezolid
• Rifabutin
• Rifapentine
Used if strains are resistant to first-line agents?
Fluoroquinolones
Levofloxacin
Moxifloxacin
Used in combination with other second- line drugs for
multidrug-resistant strains
Linezolid
Penetrates cells poorly and is active mainly against
extracellular tubercle bacilli
• Site of action is the ribosome subunit 30S
• Interferes with the synthesis of ribosomal proteins
• Ototoxic - Vertigo and hearing loss
• Nephrotoxic
Streptomycin
• Indicated for streptomycin-resistant or multidrug-resistant
strains
• Nephrotoxic
• Ototoxic - tinnitus, deafness, and vestibular disturbances
Capreomycin
Amikacin
• Indicated for streptomycin-resistant or multidrug-resistant
strains
Cycloserine
• a structural analog of D-alanine
• inhibits cell wall synthesis
Adverse effects:
• Peripheral neuropathy
• Central nervous system dysfunction
• Pyridoxine ameliorates neurologic toxicity
Ethionamide
• Blocks the synthesis of mycolic acids
• Hepatotoxic
• Neurologic symptoms may be alleviated by pyridoxine
Aminosalicylic Acid (PAS)
• structurally similar to p-amino-benzoic acid (PABA)
• folate synthesis antagonist
• very high concentrations in the urine can result in crystalluria
RIFAMYCINS
Rifabutin
• Bacterial RNA polymerase inhibitor
• Both substrate and inducer of cytochrome P450 enzymes
• Less potent inducer than Rifampin
• Often used in place of rifampin for treatment of tuberculosis in
patients with HIV infection on antiretroviral therapy
• Similar rates of hepatotoxicity compared to rifampin
Rifapentine
• Potent inducer of cytochrome P450 enzymes
• Combined with isoniazid is an effective short-course treatment for
latent tuberculosis infection
Bedaquiline
• inhibits adenosine 5′-triphosphate (ATP) synthase in
mycobacteria
• risk of QTc prolongation
Pretomanid
acts as a respiratory poison following nitric oxide release
Rifapentine
• Potent inducer of cytochrome P450 enzymes
• Combined with isoniazid is an effective short-course treatment for
latent tuberculosis infection
Rifabutin
• Bacterial RNA polymerase inhibitor
• Both substrate and inducer of cytochrome P450 enzymes
• Less potent inducer than Rifampin
• Often used in place of rifampin for treatment of tuberculosis in
patients with HIV infection on antiretroviral therapy
• Similar rates of hepatotoxicity compared to rifampin
Nasal Decongestants
Phenylephrine
• postsynaptic α-receptor stimulant
• Nasal spray to act as a decongestant in
hay fever & the common cold
Pseudoephedrine
Nasal Decongestants
Pseudoephedrine
• Similar to ephedrine - has both an
alpha and beta agonist properties
• Alpha receptor mediated
vasoconstriction in the respiratory
mucosa shrinks swollen nasal mucous
membranes
• Relief of nasal congestion or eustachian
tube congestion
Xylometazoline
α1 and α2 adrenergic agonist
• Faster acting
Nasal decongestant
Oxymetazoline
Oxymetazoline
• Long- Acting Topical Nasal
Decongestant
• Direct acting alpha agonist (1 &
2A)
• For the temporary relief of nasal
congestion or stuffiness caused
by hay fever or other allergies,
colds, or sinus trouble
Cough Suppressants (Antitussives)
Dextromethorphan
• Opioid derivative NMDA blocker
• Decreases the sensitivity of cough receptors
• Interrupts the transmission of cough impulses
by depressing the medullary cough center
• Reported to be free of addictive potential
• Produces less constipation compared to codeine
Cough Suppressants (Antitussives)
Benzonatate
• Non-narcotic
• Anesthetizes the stretch receptors and thereby
reducing the cough reflex at its source
• Symptomatic relief of cough